Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NF-kappaB activation in melanoma.

Yukiko Ueda1, Ann Richmond

  • 1Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.

Pigment Cell Research
|March 10, 2006
PubMed
Summary

Metastatic melanoma, a resistant skin cancer, involves upregulated nuclear factor-kappa B (NF-kappaB). This review explores NF-kappaB

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RAS/MEK/PI3K pathway inhibition augments response to CD40 agonism by targeting CD11b<sup>+</sup> Bregs thereby overcoming melanoma PD1-resistance.

Nature communications·2026
Same author

[Investigation of Nonvolatile Amines in Agricultural Products].

Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan·2025
Same author

Combined treatment with CDK4/6, CDK2, and CXCR1/2 inhibitors effectively halts the growth of BRAF wild-type melanoma tumors.

Frontiers in oncology·2025
Same author

Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugates.

Nature biomedical engineering·2025
Same author

[Determination of Tetrodotoxin in Miso Soup byStrong Cation Exchange Solid Phase Extraction and LC-MS/MS].

Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan·2025
Same author

A High-Throughput Immune-Oncology Screen Identifies Immunostimulatory Properties of Cytotoxic Chemotherapy Agents in TNBC.

Cancers·2024

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Metastatic melanoma is an aggressive skin cancer known for its resistance to conventional therapies.
  • Nuclear factor-kappa B (NF-kappaB) is frequently upregulated in human melanoma, disrupting normal gene transcription.

Purpose of the Study:

  • To review the intricate relationship between genetic alterations in melanoma and the upregulation of NF-kappaB.
  • To elucidate the mechanisms by which activated NF-kappaB transitions from promoting apoptosis to inhibiting it in melanoma.
  • To examine autocrine mechanisms responsible for the constitutive activation of NF-kappaB in metastatic melanoma.

Main Methods:

  • Literature review focusing on molecular mechanisms in melanoma.
  • Analysis of gene expression patterns and signaling pathways.
  • Investigation of NF-kappaB regulatory networks.

Main Results:

  • NF-kappaB upregulation is linked to gene alterations driving melanoma progression.
  • Activated NF-kappaB can shift its function to promote melanoma cell survival.
  • Autocrine signaling contributes to sustained NF-kappaB activation in metastatic disease.

Conclusions:

  • Understanding NF-kappaB's role is crucial for developing novel melanoma treatments.
  • Targeting NF-kappaB signaling pathways may overcome therapeutic resistance in metastatic melanoma.

Related Experiment Videos